Holen Sie sich die Stockscreener-App
10.77
0.28%
-0.03
Replimune Group Inc Aktie (REPL) Neueste Nachrichten
Replimune Group Q3 EPS Forecast Decreased by Leerink Partnrs - Defense World
What is Wedbush's Estimate for Replimune Group Q3 Earnings? - MarketBeat
HC Wainwright Predicts Stronger Earnings for Replimune Group - MarketBeat
Leerink Partnrs Weighs in on Replimune Group Q3 Earnings - MarketBeat
Significant Stake Increase by Baker Bros. Advisors in Replimune Group Inc - GuruFocus.com
Brokerages Set Replimune Group, Inc. (NASDAQ:REPL) Target Price at $16.80 - Defense World
When (REPL) Moves Investors should Listen - Stock Traders Daily
Replimune Group’s Q3 2024 Financial Highlights - TipRanks
Replimune Group (NASDAQ:REPL) Receives Buy Rating from HC Wainwright - MarketBeat
Replimune Reports $432.1M Cash Position, Advances Melanoma Treatment BLA Plans | REPL Stock News - StockTitan
Replimune stock soars to 52-week high, touches $12.86 By Investing.com - Investing.com Australia
Analysts Set Replimune Group, Inc. (NASDAQ:REPL) Price Target at $16.80 - MarketBeat
Replimune Group Inc. (REPL) Quarterly 10-Q Report - Quartzy
Replimune stock soars to 52-week high, touches $12.86 - Investing.com India
Replimune Group (NASDAQ:REPL) Hits New 52-Week HighStill a Buy? - MarketBeat
Creative Planning Buys 4,699 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune's RP1 Shows 33.6% Response Rate in Melanoma Trial, Marks Breakthrough | REPL Stock News - StockTitan
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Replimune Group Awards Stock Options, RSUs to New Employees in Retention Move | REPL Stock News - StockTitan
TSX Consumer Staples Capped Index (TTCS) QuotePress Release - The Globe and Mail
KBW Bank Index (BKX) QuotePress Release - The Globe and Mail
Itron Inc (ITRI-Q) QuotePress Release - The Globe and Mail
Vanguard Group's Strategic Acquisition in Replimune Group Inc - GuruFocus.com
Teledyne Technologies Inc (TDY-N) QuotePress Release - The Globe and Mail
Replimune to Present at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - The Manila Times
Masco Corp (MAS-N) QuotePress Release - The Globe and Mail
Skechers U.S.A. (SKX-N) QuotePress Release - The Globe and Mail
S&P GSCI Index (GNX) QuotePress Release - The Globe and Mail
Non-melanoma Skin Cancer is Predicted to Exhibit Remarkable Growth During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.
SG Americas Securities LLC Invests $251,000 in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Given Average Recommendation of "Buy" by Analysts - MarketBeat
It would be worthwhile to take a closer look at Replimune Group Inc (REPL) - US Post News
Daily Progress: Replimune Group Inc (REPL) Drop -7.06, Closing at 10.67 - The Dwinnex
Replimune Group Inc [REPL] Insider Selling: Time to sell? - Knox Daily
Replimune Group Inc Inc. (REPL) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Replimune Group (NASDAQ:REPL) Stock Price Down 5.2%Here's What Happened - MarketBeat
Learn to Evaluate (REPL) using the Charts - Stock Traders Daily
Cubist Systematic Strategies LLC Buys 53,313 Shares of Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat
Gaining Ground: Replimune Group Inc (REPL) Closes Higher at 11.74, Up 3.62 - The Dwinnex
Investing in Replimune Group Inc (REPL) Is Getting More Attractive - Knox Daily
Replimune Group, Inc. (NASDAQ:REPL) Shares Sold by Dimensional Fund Advisors LP - MarketBeat
Morgan Stanley's Strategic Reduction in Replimune Group Inc Holdings - GuruFocus.com
Cubist Systematic Strategies LLC Increases Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Shares Purchased by Millennium Management LLC - MarketBeat
Chief Financial Officer Hill Emily Luisa sale 8,938 shares of Replimune Group Inc [REPL] - Knox Daily
Insiders At Replimune Group Sold US$863k In Stock, Alluding To Potential Weakness - Simply Wall St
Replimune Group (NASDAQ:REPL) Sees Strong Trading Volume - MarketBeat
REPL’s Stock Market Adventure: 41.16% YTD Growth Amidst Volatility - The InvestChronicle
Replimune Group (NASDAQ:REPL) Trading Up 6.1% - Defense World
Is it possible to buy Replimune Group Inc(REPL) shares at a good price now? - US Post News
Replimune to Present at Two Upcoming Investor Conferences - The Manila Times
Replimune Group, Inc. (NASDAQ:REPL) Shares Sold by XTX Topco Ltd - Defense World
Keeping an Eye on Replimune Group Inc (REPL) After Insider Trading Activity - Knox Daily
Analytical Overview: Replimune Group Inc (REPL)’s Ratios Tell a Financial Story - The Dwinnex
Replimune Group Inc (REPL) expanding its growth trajectory ahead - SETE News
Replimune Group's SWOT analysis: biotech stock poised for growth amid challenges - Investing.com
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):